Neoplasia/BPH

	Risk Stratification of Suspected Clinically Localized Prostate Cancer Using Multi-Indicator Functional Differentiation: A Predictive Model With fPSA/tPSA, PHI, PCA3, and MRI. Arch Esp Urol Li L, Xu Y, Chen M. PMID: 42104706 [PubMed - indexed for MEDLINE]
	Predictors of BCG Therapy Complications in Non-Muscle-Invasive Bladder Cancer: A Clavien-Dindo-Based Study. Arch Esp Urol Turan T, Efiloglu O, Hamidzada I, Ahmadzada J, Polat S, Yildirim A. PMID: 42104704 [PubMed - indexed for MEDLINE]
	Correlation of Serum Adiponectin and Metabolic Syndrome Components With Prostate Cancer Susceptibility and Construction of a Nomogram Prediction Model. Arch Esp Urol Cheng L, Zhou X, Pan J, Xing Y, Fu J, Zhang W, Zhang Z. PMID: 42104702 [PubMed - indexed for MEDLINE]
	Heart Rate Variability as a Novel Indicator for Predicting Postoperative Urinary Retention in Benign Prostatic Hyperplasia: Development and Internal Validation of a Predictive Nomogram. Arch Esp Urol Qin Y, Song X, Zhang W, Chen B. PMID: 42104701 [PubMed - indexed for MEDLINE]
	Genetically Predicted Gut Microbiota and Bladder Cancer Risk: A Mendelian Randomisation Analysis. Arch Esp Urol Wei F, Zhao M, Sun X, Ma H, Yin H, Shen X, Chen S. PMID: 42104697 [PubMed - indexed for MEDLINE]
	Association of Inflammatory and Nutritional Biomarkers with Pathological Response in Patients with Muscle-invasive Bladder Carcinoma Treated with Neoadjuvant Chemotherapy. Arch Esp Urol Navarro-Jiménez S, Carrión-López P, Lorenzo-Sánchez MV, Tárraga-Honrubia MA, Díaz-de-Mera-Sánchez-Migallón I, Giménez-Bachs JM, Salinas-Sánchez AS. PMID: 42104694 [PubMed - indexed for MEDLINE]
	Development of a Novel Nomogram to Predict Biochemical Failure and Prostate Cancer-Specific Mortality After Definitive Radiotherapy in Patients with Gleason Score 7 Prostate Cancer. Arch Esp Urol Elmal A, Demirhan B, Senturk E, Guler OC, Erpolat P, Onal C. PMID: 42104693 [PubMed - indexed for MEDLINE]
	Comparative Analysis of Greenlight Laser Photovaporization and Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia Surgery. Arch Esp Urol García Rico E, Ortega Polledo LE, Sánchez Pellejero A, Bianchini Hernández G, Gómez Rivas J, Sanchis Bonet A, Galante Romo I, Moreno Sierra J, Alonso Y Gregorio S. PMID: 42104692 [PubMed - indexed for MEDLINE]
	Current Evidence on the Use of Cystoscopy in the Follow-up of Non-Muscle-Invasive Bladder Cancer: Are We Overusing It? Systematic Review of the Literature. Arch Esp Urol Baudet León J, Caño Velasco J, Polanco Pujol L, Artero Fullana S, Pastor Rodenas B, Subiela Henriquez JD, García Martín LA, Hernández Fernández C, Bielsa Carrillo A. PMID: 42104689 [PubMed - indexed for MEDLINE]
	Risk Assessment of Non-Urinary Tract Recurrence After Radical Nephroureterectomy Based on CheckMate 274 Trial Eligibility: A Multicenter Retrospective Study. Int J Urol Shindo T, Ueki Y, Muranaka I, Kobayashi G, Miyamoto S, Kunishima Y, Sato S, Okada M, Kato S, Kato R, Adachi H, Matsukawa M, Takayanagi A, Shibamori K, Wanifuchi A, Kyoda Y, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. PMID: 42104674 [PubMed - indexed for MEDLINE]
	The low-grade Inflammation Score (INFLA-Score) as a predictor of overall survival in prostate cancer: a UK biobank cohort study. BMC Urol Jiang S, Zheng X, Qiu H, Tao N, An H. PMID: 42104304 [PubMed - as supplied by publisher]
	The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial. Oncologist Guerrero-Ramos F, Gómez-Cañizo C, Rodríguez-Izquierdo M, Hernández-Arroyo M, Rodríguez-Antolín A, de Velasco G, Ponce-Aix S, Paramio JM, Suárez-Cabrera C, Rubio C, Morales L, García-Martínez V, Dueñas M, Castellano D. PMID: 42103978 [PubMed - as supplied by publisher]
	PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers. Eur Urol Oncol Shadbahr T, Pylväläinen J, Eineluoto J, Moro A, Kerro O, Kenttämies A, Czeizler E, Murtola TJ, Kim-Ollila HJ, Puech P, Olivier J, Villers A, Peltonen J, Nykter M, Tang J, Mirtti T, Laajala TD, Rannikko AS. PMID: 42103551 [PubMed - as supplied by publisher]
	Renal presentation of diffuse large B-cell lymphoma emerging after pre-existing IgG4-related disease and monoclonal gammopathy of undetermined significance. BMJ Case Rep Jlasi A, Gomez A, Deng X. PMID: 42103345 [PubMed - indexed for MEDLINE]
	Expert practical recommendations for optimising tumour and germline testing of homologous recombination repair gene mutations in metastatic prostate cancer. Rev Esp Patol González-Peramato P, García-Fernández E, Jambrina A, Salinas JF, Hernández-Losa J, Linares-Espinós E, Rojo F, Mateo J, Olmos D. PMID: 42102633 [PubMed - as supplied by publisher]
	Pathological assessment of morcellated tissue after ERBT: insights from a two-round Delphi survey. World J Urol Ventura Y, Morozov A, Chan R, Combat Faria Tavares M, Teoh JY, Compérat E, Cheng L, Fridman E, Lerner J, Baraban E, Yakimov M, Lokshin K, Lifshitz D, Golan S, Gauhar V, Herrmann TRW, Shariat S, Enikeev D. PMID: 42101641 [PubMed - indexed for MEDLINE]
	A multicenter study of automatic segmentation-based multimodal fusion integrating radiomics, deep learning, and clinical parameters for prostate cancer detection. Abdom Radiol (NY) Ding N, Jin L, Yin S, Ji Y, Wang X, Li M. PMID: 42101624 [PubMed - as supplied by publisher]
	The Impact of Specialist Palliative Care on the Utilization of Health Care Services at the End of Life Among Patients With Prostate Cancer: A Nationwide Register-based Study. Eur Urol Open Sci Carpén TP, Nåhls NA, Nuutinen MSJ, Saarto TH. PMID: 42100443 [PubMed]
	Abdominal disseminated lesions following surgery for a testicular mucinous cystic neoplasm initially diagnosed as mucinous cystadenoma: a case report and literature review. Front Oncol Yang J, Li W, Wang J, Li J. PMID: 42100427 [PubMed]
	Aerobic glycolysis in bladder cancer: research advances and targeted therapy potential. Front Oncol Pan M, Tao T, Kong D, Gong H. PMID: 42100416 [PubMed]

Articles 1 - 20 / 187686

Page 1 of 9385



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy